Ameet Mallik Adc Therapeutics Sa (ADCT) insider trading activity

Ameet Mallik is Chief Executive Officer of ADC Therapeutics SA. Currently has a direct ownership of 1.32 Million shares of ADCT, which is worth approximately $5.22 Million. The most recent transaction as insider was on Dec 06, 2025, when has been sold 233,146 shares (Common Shares) at a price of $3.29 per share, resulting in proceeds of $767,050. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.32M

15.02% 3M change

41.99% 12M change

Total Value Held $5.22 Million

AMEET MALLIK Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 06 2025	SELL Payment of exercise price or tax liability	$767,050 $3.29 p/Share	233,146 Reduced 15.02%	1,319,101 Common Shares
May 06 2025	SELL Payment of exercise price or tax liability	$34,517 $1.29 p/Share	26,758 Reduced 1.69%	1,552,247 Common Shares
Feb 13 2025	BUY Grant, award, or other acquisition	$1,046,500 $1.61 p/Share	650,000 Added 29.16%	1,579,005 Common Shares
Dec 06 2024	SELL Payment of exercise price or tax liability	$746,013 $3.13 p/Share	238,343 Reduced 20.42%	929,005 Common Shares
May 07 2024	SELL Open market or private sale	$133,194 $4.48 p/Share	29,731 Reduced 2.48%	1,167,348 Common Shares

Also insider at

RFL

Rafael Holdings, Inc. Real Estate

Director

ATRA

Atara Biotherapeutics, Inc. Healthcare

Ameet Mallik

Chief Executive Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADCT shares.

Notify only if

Value

Insider Trading

Get notified when an Adc Therapeutics Sa insider buys or sells ADCT shares.

Notify only if

Operation

Value

Type

News

Receive news related to ADC Therapeutics SA

Track Activities on ADCT

Account